antiviral news
Press Releases in the global landscape
May 4, 2026
Nirmatrelvir–ritonavir does not improve severe outcomes in adults vaccinated against COVID-19
Study found nirmatrelvir–ritonavir did not reduce severe outcomes in vaccinated COVID-19 patients, though symptom recovery improved.
Read More »
Apr 23, 2026
St. Michael’s Hospital’s Upstream Lab uncovers new evidence which could shape decisions on Paxlovid use for COVID-19
St. Michael’s Hospital’s Upstream Lab uncovers new evidence which could shape decisions on Paxlovid use for COVID-19
Read More »
Apr 22, 2026
If It's COVID, Paxlovid? Studies Suggest a Rethink These Days
Studies suggest Paxlovid may not prevent severe COVID-19 outcomes in vaccinated individuals but could reduce recovery time and viral load.
Read More »
Mar 24, 2026
ACP updates outpatient COVID-19 treatment guidance
The American College of Physicians updated outpatient COVID-19 treatment guidelines, outlining best practices for medication use in confirmed cases.
Read More »
Mar 24, 2026
Japan approves preventive use of oral COVID drug Xocova in world first
Japan approved the preventive use of the oral COVID-19 antiviral Xocova, marking the first authorization of its kind globally.
Read More »
Mar 23, 2026
Antiviral drug "Paquirovid(R) Pack 600/300" received approval for additional indication for children aged 6 years and older and weighing 20 kg or more - New treatment option for patients infected with COVID-19 -
Antiviral drug "Paquirovid(R) Pack 600/300" received approval for additional indication for children aged 6 years and older and weighing 20 kg or more - New treatment option for patients infected with COVID-19 -
Read More »